Wells Fargo’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,125
| Closed | -$2K | – | 7607 |
|
2022
Q2 | $2K | Sell |
1,125
-489
| -30% | -$869 | ﹤0.01% | 6143 |
|
2022
Q1 | $3K | Hold |
1,614
| – | – | ﹤0.01% | 6282 |
|
2021
Q4 | $3K | Buy |
1,614
+1
| +0.1% | +$2 | ﹤0.01% | 6294 |
|
2021
Q3 | $5K | Buy |
1,613
+39
| +2% | +$121 | ﹤0.01% | 6072 |
|
2021
Q2 | $4K | Sell |
1,574
-1,997
| -56% | -$5.08K | ﹤0.01% | 6092 |
|
2021
Q1 | $7K | Buy |
3,571
+2
| +0.1% | +$4 | ﹤0.01% | 6065 |
|
2020
Q4 | $9K | Sell |
3,569
-2,000
| -36% | -$5.04K | ﹤0.01% | 5772 |
|
2020
Q3 | $11K | Buy |
5,569
+53
| +1% | +$105 | ﹤0.01% | 5572 |
|
2020
Q2 | $16K | Sell |
5,516
-2,500
| -31% | -$7.25K | ﹤0.01% | 5431 |
|
2020
Q1 | $21K | Sell |
8,016
-1,484
| -16% | -$3.89K | ﹤0.01% | 5333 |
|
2019
Q4 | $47K | Buy |
9,500
+500
| +6% | +$2.47K | ﹤0.01% | 5277 |
|
2019
Q3 | $54K | Buy |
9,000
+2,000
| +29% | +$12K | ﹤0.01% | 5257 |
|
2019
Q2 | $45K | Buy |
7,000
+500
| +8% | +$3.21K | ﹤0.01% | 5291 |
|
2019
Q1 | $44K | Buy |
6,500
+500
| +8% | +$3.39K | ﹤0.01% | 5258 |
|
2018
Q4 | $24K | Buy |
+6,000
| New | +$24K | ﹤0.01% | 5395 |
|